Article
[Perspectives for molecular diagnostics exemplified by urothelial bladder carcinoma].
Der Urologe. Ausg. A - 1 May 2003
Grimm M-O, Burchardt M, Schulz W A
Abstract excerpt
The rapidly growing knowledge of molecular mechanisms will change the daily routine of clinicians in the near future. Regarding urothelial bladder carcinoma, one may expect that molecular diagnostics will identify patients susceptible to disease development by screening their genotype. Furthermore, in addition to histopathologic findings, prognostic markers will be used for disease management. In an ongoing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.